# Irene

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/irene
Canonical HTML page: https://gethealthbrief.com/entity/irene

## Timeline

- **2026-08-13**: NPR report details mixed rollout reviews in Uganda — A syndicated story from Kalisizo, Uganda highlights participant Irene's experience, the drug's six-month protection, and ongoing implementation challenges.
- **2024**: PURPOSE 1 and PURPOSE 2 deliver unprecedented efficacy — An independent monitoring committee concluded lenacapavir was so effective that the randomized phase of both trials was halted early.

## Recent coverage (1 stories)

### Lenacapavir's 6-Month HIV PrEP Shows Promise, Rollout Gets Mixed Reviews
2026-08-13 15:39:34 · Sentiment: Neutral · Impact: 7/10 · Sources: 3

A twice-yearly injectable PrEP, lenacapavir showed unprecedented efficacy in the PURPOSE 1 and 2 trials, yet its rollout in Uganda is drawing mixed reviews. For health systems, the drug's adherence-friendly profile must clear delivery, access, and stigma barriers to achieve population-level impact.
Full story: https://gethealthbrief.com/story/lenacapavir-six-month-hiv-prep-rollout-mixed-reviews-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.